中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月15日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2024, Vol. 31 Issue (1): 39-42,46    
  心血管疾病 本期目录 | 过刊浏览 | 高级检索 |
全胸腔镜微创在心脏手术中的应用
许发珍1 陈凯明2 朱 铭1 苏少萍1
1.广东省惠州市中心人民医院心脏大血管外科,广东惠州 516000 2.广东省高州市人民医院心血管外科,广东高州 525200
Application of total thoracoscopic minimally invasive in cardiac surgery
XU Fazhen1 CHEN Kaiming2 ZHU Ming1 SU Shaoping1
1. Department of Cardiac Vascular Surgery, Huizhou Municipal Central Hospital, Guangdong Province, Huizhou 516000, China 2. Department of Vascular Surgery, People's Hospital of Gaozhou, Guangdong Province, Gaozhou 525200, China
全文: PDF (685 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨全胸腔镜微创手术在体外循环心脏瓣膜术中的应用效果。方法 选取2022年4月至2023年4月惠州市中心人民医院和高州市人民医院接受体外循环心脏瓣膜手术的60例患者作为研究对象,按照随机数字表法分为A组(30)、B组(30例)。A组行全胸腔镜微创心脏手术,B组行传统正中开胸心脏手术。比较两组相关手术指标、术后疼痛评分、并发症发生情况及手术前后应激反应指标变化情况。结果 A组手术时间、体外循环时间、主动脉阻断时间长于B组,术中出血量、输血量少于B组,差异有统计学意义(P<0.05)。A组术后引流量少于B组,术后呼吸机使用时间、ICU停留时间短于B组,差异有统计学意义(P<0.05);A组术后第1天、术后第三日伤口疼痛评分低于B组,差异有统计学意义(P<0.05);A组术后并发症总发生率低于B组,差异有统计学意义(P<0.05)。两组术前身体应激反应指标比较,差异无统计学意义(P>0.05),两组术后72 h的肾上腺素、去甲肾上腺素、皮质醇水平均高于术前,但A组的肾上腺素、去甲肾上腺素、皮质醇水平低于B组,差异有统计学意义(P<0.05)。结论 比较正中开胸心脏手术,全胸腔镜微创体外循环心脏瓣膜手术术中出血量、输血量低、术后恢复快、术后并发症少等优势。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
许发珍1 陈凯明2 朱 铭1 苏少萍1
关键词 全胸腔镜微创心脏手术正中开胸手术并发症体外循环心脏瓣膜手术    
Abstract:Objective To analyze the application effect of total thoracoscopy minimally invasive cardiac surgery. Methods From April 2022 to April 2023, 60 patients of undergoing the cardiopulmonary bypass cardiac valve surgery in Huizhou Municipal Central Hospital and the People's Hospital of Gaozhou were chosen as the study subjects, according to the random number table method, they were divided into group A (30) and group B (30 cases). Group A received total thoracoscopy minimally invasive heart surgery, and group B received traditional median thoracotomy. The relevant surgical indicators, postoperative pain scores, and incidence of complications between two groups were compared. Results The surgical time, extracorporeal circulation time, and aortic occlusion time in group A were longer than those in group B, while the blood loss and transfusion volume were lower than those in group B, with statistically significant differences (P<0.05). The postoperative drainage volume in group A was lower than that in group B, and the postoperative ventilator use time and ICU stay time were shorter than those in group B, with statistically significant differences (P<0.05). The wound pain score on the first and third postoperative days in group A was lower than those in group B, with statistically significant difference (P<0.05). The total incidence of postoperative complications in group A was lower than that in group B, with a statistically significant difference (P<0.05). There were no statistically significant differences in the comparison of physical stress response indicators between the groups before operation (P>0.05). The levels of adrenaline, norepinephrine and cortisol of the two groups 72 hours after operation were higher than before operation, and the norepinephrine and cortisol in the group A were lower than those in the group B, with statistically significant differences (P<0.05). Conclusion Compared with median open heart surgery, total thoracoscopy minimally invasive cardiopulmonary bypass heart valve surgery has the advantages of low trauma, rapid postoperative recovery, and fewer postoperative complications.
Key wordsTotal thoracoscopic cardiac surgery    Median sternotomy    Complications    Cardiopulmonary bypass
    
基金资助:[基金项目]广东省惠州市医疗领域科技计划项目(2022CZ0 10085)。
通讯作者: 陈凯明(1976-),男,主任医师,主要从事胸心外科方向的研究。   
作者简介: 许发珍(1979-),男,主任医师,主要从事胸心外科方向的研究。
引用本文:   
许发珍1 陈凯明2 朱 铭1 苏少萍1. 全胸腔镜微创在心脏手术中的应用[J]. 中国当代医药, 2024, 31(1): 39-42,46.
XU Fazhen1 CHEN Kaiming2 ZHU Ming1 SU Shaoping1. Application of total thoracoscopic minimally invasive in cardiac surgery. 中国当代医药, 2024, 31(1): 39-42,46.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2024/V31/I1/39
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载